10-Q: ACM Research Q3 Revenue Jumps 32%, Margins Decline

ACM Research, Inc. reported a 32% increase in third-quarter revenue to $269.16 million, driven by strong growth across all product categories, despite a notable decline in gross margin and operating income.

Summary

• Revenue for the three months ended September 30, 2025, increased by 32.0% to $269.16 million, compared to $203.98 million in the same period of 2024.
• Revenue for the nine months ended September 30, 2025, increased by 17.6% to $656.88 million, compared to $558.65 million in the same period of 2024.
• Gross margin decreased to 42.0% for the three months ended September 30, 2025, from 51.4% in the prior-year period, primarily due to revenue mix and higher inventory provisions.
• Gross margin for the nine months ended September 30, 2025, was 45.7%, down from 50.3% in the prior-year period.
• Income from operations for the three months ended September 30, 2025, decreased by 34.5% to $28.92 million, from $44.18 million in the prior-year period.
• Net income attributable to ACM Research, Inc. for the three months ended September 30, 2025, increased by 16.1% to $35.89 million, or $0.52 per diluted share.
• Net income attributable to ACM Research, Inc. for the nine months ended September 30, 2025, increased by 18.6% to $86.03 million, or $1.26 per diluted share.
• Net cash used in operating activities for the nine months ended September 30, 2025, was $44.24 million, a significant shift from $63.86 million provided in the prior-year period.
• Free cash flow for the nine months ended September 30, 2025, was negative $87.20 million, compared to negative $15.96 million in the prior-year period.
• ACM Shanghai completed a private offering in September 2025, issuing 38.6 million ordinary shares and raising approximately $623.0 million, which reduced ACM Research's equity interest in ACM Shanghai from 81.1% to 74.6%.
• Total shipments for the nine months ended September 30, 2025, decreased to $626.2 million from $709.6 million in the same period of 2024.

Sentiment

Score: 5

Explanation: The company shows strong revenue growth, but this is offset by significant gross margin compression, a decline in operating income, and a shift to negative cash flow from operations and free cash flow. The substantial capital raise is positive for liquidity but also diluted ownership. Geopolitical and regulatory risks add to the mixed outlook.

Positives

• Revenue for the three months ended September 30, 2025, increased by 32.0% to $269.16 million, demonstrating strong top-line growth.
• Net income attributable to ACM Research, Inc. for the three months ended September 30, 2025, increased by 16.1% to $35.89 million.
• Net income attributable to ACM Research, Inc. for the nine months ended September 30, 2025, increased by 18.6% to $86.03 million.
• Unrealized gain on short-term investments significantly increased to $18.66 million for the three months and $20.30 million for the nine months ended September 30, 2025, compared to prior periods.
• Income from equity method investments grew substantially by 178.9% to $3.67 million for the three months and 6231.7% to $6.40 million for the nine months ended September 30, 2025.
• ACM Shanghai successfully completed a private offering, raising approximately $623.0 million for research and development, capital expenditures, and working capital.
• The company's current product portfolio addresses an estimated $20 billion of the 2025 global wafer fab equipment market.

Negatives

• Gross margin significantly decreased to 42.0% for the three months ended September 30, 2025, from 51.4% in the prior-year period, and to 45.7% for the nine months from 50.3%.
• Income from operations decreased by 34.5% to $28.92 million for the three months and by 19.2% to $86.39 million for the nine months ended September 30, 2025.
• Cost of revenue increased by 57.4% for the three months and 28.4% for the nine months ended September 30, 2025, outpacing revenue growth.
• Total operating expenses increased by 38.9% for the three months and 23.0% for the nine months ended September 30, 2025.
• Net cash used in operating activities was $44.24 million for the nine months ended September 30, 2025, a reversal from $63.86 million provided in the prior-year period.
• Free cash flow was negative $87.20 million for the nine months ended September 30, 2025, worsening from negative $15.96 million in the prior-year period.
• Total shipments decreased to $626.2 million for the nine months ended September 30, 2025, from $709.6 million in the prior-year period, with both repeat and first tool shipments declining.
• The company's equity interest in ACM Shanghai declined from 81.1% to 74.6% due to the private offering.

Risks

• Mainland China central government authorities may intervene in or influence ACM Shanghai's operations, and rules can change quickly with little advance notice.
• Existing mainland China laws or regulations, or interpretations thereof, may require ACM Shanghai to obtain permission or approval to continue the listing of ACM Research's Class A common stock in the United States, which could have a material adverse effect.
• The U.S. Holding Foreign Companies Accountable Act (HFCA Act) could lead to delisting if the independent auditor is located in a jurisdiction that does not allow for PCAOB inspections for two consecutive years.
• The addition of ACM Shanghai and ACM Korea to the U.S. Department of Commerce's Bureau of Industry and Security (BIS) Entity List restricts the furnishing of U.S. export-controlled hardware, software, or technologies.
• The U.S. Outbound Investment Security Program (OISP) limits cross-border investment opportunities, especially those related to China, potentially preventing advantageous investments.
• Covenants in ACM Lingang's Grant Contract for State-owned Construction Land Use Right require minimum annual sales or tax payments by July 9, 2027, with potential liquidated damages or termination and land take-back if not met.
• An ongoing inquiry from the Seoul Customs Office regarding certain goods produced and shipped by ACM Korea to overseas markets, though not currently believed to have a material effect, is subject to uncertainties and further developments.

Future Outlook

Management expects gross margin to be between 42.0% and 48.0% for the foreseeable future. Sales and marketing, research and development, and general and administrative expenses are expected to increase in dollars as the company expands its customer base, product portfolio, and global R&D team, and manages its public company operations in both the U.S. and mainland China. Existing cash, operating cash flow, and bank borrowings are believed to be sufficient to meet anticipated cash needs for at least the next 12 months, though additional funding may be sought for acquisitions or if current sources are insufficient.

Management Comments

• Expect gross margin to be between 42.0% and 48.0% for the foreseeable future.
• Sales and marketing expenses will increase in dollars as we incur additional costs associated with growing our customer base in mainland China and regions outside of mainland China.
• Research and development expenses will increase in dollars as we incur additional costs to expand our product portfolio and expand our research and development team to new regions.
• General and administrative expenses will increase in dollars as we incur additional costs associated with growing our business, operating ACM Research as a public company in the United States and operating ACM Shanghai as a public company in mainland China.
• Believe existing cash and cash equivalents, time deposits, cash flow from operating activities, and bank borrowings will be sufficient to meet anticipated cash needs for at least the next 12 months.

Industry Context

The company operates in the global semiconductor industry, supplying capital equipment. Gartner estimates the total worldwide semiconductor Wafer Fab Equipment (WFE) market grew by 8.6% in 2024 to $111.6 billion and is estimated to increase by 4.7% to $116.8 billion in 2025. However, the China WFE market is expected to decrease by 17.1% to $33.5 billion in 2025. The company's strong revenue growth, particularly in Q3, suggests it is outperforming the broader WFE market trends, especially within the challenging China market.

Comparison to Industry Standards

• ACM Research's Q3 2025 revenue growth of 32.0% significantly outpaces Gartner's estimated 4.7% growth for the total worldwide Wafer Fab Equipment (WFE) market in 2025.
• The company's performance is particularly strong given Gartner's estimate of a 17.1% decrease in the China WFE market for 2025, indicating potential market share gains or strong demand in specific segments within China.
• The company's current product portfolio addresses an estimated $20 billion of the 2025 global WFE market, with specific opportunities identified in wafer cleaning equipment ($7.0 billion), PECVD equipment ($5.1 billion), Track equipment ($2.9 billion), furnace equipment ($2.6 billion), and ECP equipment ($1.4 billion).

Legal Proceedings

• ACM Korea received inquiries from the Seoul Customs Office regarding certain goods produced and shipped to overseas markets. The investigation is ongoing and in preliminary stages, but the company does not believe it will have a material effect on its financial condition or results of operations at this time.

Related Party Transactions

• Ninebell Co., Ltd., an equity investee, is the principal supplier of robotic delivery system subassemblies. Purchases of materials from Ninebell were $17.84 million for Q3 2025 and $44.85 million for 9M 2025.
• Shengyi Semiconductor Technology Co., Ltd., an equity investee, is a component supplier. Purchases of materials from Shengyi were $5.54 million for Q3 2025 and $11.53 million for 9M 2025. Service fees charged by Shengyi were $0.29 million for Q3 2025 and $2.19 million for 9M 2025.

Stakeholder Impact

• Shareholders: Experienced dilution of ACM Research's equity interest in ACM Shanghai due to the private offering. Potential impact on share price from mixed financial results and significant regulatory risks. Management and board members adopted Rule 10b5-1 trading arrangements for stock options.
• Employees: Continue to receive stock-based compensation as part of their remuneration.
• Customers: Mainland China-based customers show a longer-term commitment to increase production capacity. The company continues to deliver 'first tools' for customer evaluation, indicating ongoing engagement and potential future sales.
• Creditors: The company secured new long-term loan facilities from various banks, including China CITIC Bank, Industrial and Commercial Bank of China, and Agricultural Bank of China, increasing its debt obligations. Loan covenants require compliance with financial metrics like year-end outstanding interest-bearing debt not exceeding five times annual EBITDA.

Next Steps

• Expand direct sales teams and increase global marketing activities to address customers in North America, Western Europe, and Southeast Asia.
• Expand the product portfolio to address additional production steps.
• Expand the research and development team to new regions.
• Continue to take advantage of mainland China government-sponsored grant and subsidy programs when available and aligned with business strategy.

Key Dates

Recommendation

ACM Research demonstrates strong revenue growth, significantly outperforming the broader WFE market and the declining China WFE market. This indicates robust demand for its products and potential market share gains. However, this growth comes at the cost of substantial gross margin compression and a decline in operating income. The shift to negative cash flow from operations and free cash flow for the nine-month period is a concern for liquidity and sustainability. Furthermore, the company faces significant geopolitical and regulatory risks, including U.S. export controls and potential Chinese government intervention. While the recent capital raise strengthens the balance sheet, the mixed financial performance and elevated risk profile suggest a 'hold' recommendation, advising investors to monitor margin trends, cash flow generation, and the evolving regulatory landscape before making further investment decisions.

Keywords

Semiconductor equipment, Wafer fab equipment, Wet cleaning, Advanced packaging, ECP, Furnace, China semiconductor, R&D, Capital equipment, ACMR, Shanghai STAR Market